Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 -0.811M
March 31, 2026 -0.025M
December 31, 2025 -0.18M
September 30, 2025 -0.162M
June 30, 2025 -0.102M
March 31, 2025 -0.023M
December 31, 2024 -0.105M
September 30, 2024 -0.484M
June 30, 2024 -0.173M
March 31, 2024 -0.348M
December 31, 2023 -0.024M
September 30, 2023 -64.54M
June 30, 2023 -0.189M
March 31, 2023 -0.148M
December 31, 2022 -23.29M
September 30, 2022 0.00
June 30, 2022 -0.003M
March 31, 2022 -0.004M
December 31, 2021 0.00
September 30, 2021 -0.017M
June 30, 2021 0.267M
March 31, 2021 0.03M
December 31, 2020 0.021M
September 30, 2020 0.008M
June 30, 2020 0.00
Date Value
March 31, 2020 0.00
December 31, 2019 -0.634M
September 30, 2019 0.044M
June 30, 2019 -0.017M
March 31, 2019 -0.162M
December 31, 2018 -1.59M
September 30, 2018 -2.644M
June 30, 2018 -0.519M
March 31, 2018 -0.122M
December 31, 2017 -0.962M
September 30, 2017 -0.162M
June 30, 2017 -0.178M
March 31, 2017 -2.941M
December 31, 2016 -13.78M
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 -11.14M
December 31, 2015 0.01M
September 30, 2015 0.00
June 30, 2015 -1.171M
March 31, 2015 -0.077M
December 31, 2014 -0.0004M
September 30, 2014 -0.1372M
June 30, 2014 -0.1345M
March 31, 2014 -0.3496M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 149.30M
Zevra Therapeutics, Inc. -0.435M
Indivior Pharmaceuticals, Inc. 175.35M
Liquidia Corp. -1.443M
60 Degrees Pharmaceuticals, Inc. 0.00